Rate responsive leadless cardiac pacemaker

Information

  • Patent Grant
  • 7937148
  • Patent Number
    7,937,148
  • Date Filed
    Friday, October 13, 2006
    19 years ago
  • Date Issued
    Tuesday, May 3, 2011
    15 years ago
Abstract
A leadless cardiac pacemaker comprises a housing, a plurality of electrodes coupled to an outer surface of the housing, and a pulse delivery system hermetically contained with the housing and electrically coupled to the electrode plurality, the pulse delivery system configured for sourcing energy internal to the housing, generating and delivering electrical pulses to the electrode plurality. The pacemaker further comprises an activity sensor hermetically contained within the housing and adapted to sense activity and a processor hermetically contained within the housing and communicatively coupled to the pulse delivery system, the activity sensor, and the electrode plurality, the processor configured to control electrical pulse delivery at least partly based on the sensed activity.
Description
BACKGROUND

Cardiac pacing electrically stimulates the heart when the heart's natural pacemaker and/or conduction system fails to provide synchronized atrial and ventricular contractions at appropriate rates and intervals for a patient's needs. Such bradycardia pacing provides relief from symptoms and even life support for hundreds of thousands of patients. Cardiac pacing may also give electrical overdrive stimulation intended to suppress or convert tachyarrhythmias, again supplying relief from symptoms and preventing or terminating arrhythmias that could lead to sudden cardiac death.


Cardiac pacing is usually performed by a pulse generator implanted subcutaneously or sub-muscularly in or near a patient's pectoral region. The generator usually connects to the proximal end of one or more implanted leads, the distal end of which contains one or more electrodes for positioning adjacent to the inside or outside wall of a cardiac chamber. The leads have an insulated electrical conductor or conductors for connecting the pulse generator to electrodes in the heart. Such electrode leads typically have lengths of 50 to 70 centimeters.


Known pulse generators can include various sensors for estimating metabolic demand, to enable an increase in pacing rate proportional and appropriate for the level of exercise. The function is usually known as rate-responsive pacing. For example, an accelerometer can measure body motion and indicate activity level. A pressure transducer in the heart can sense the timing between opening and closing of various cardiac valves, or can give a measure of intracardiac pressure directly, both of which change with changing stroke volume. Stroke volume increases with increased activity level. A temperature sensor can detect changes in a patient's blood temperature, which varies based on activity level. The pacemaker can increase rate proportional to a detected increase in activity.


Pulse generator parameters are usually interrogated and modified by a programming device outside the body, via a loosely-coupled transformer with one inductance within the body and another outside, or via electromagnetic radiation with one antenna within the body and another outside.


Although more than one hundred thousand rate-responsive pacemakers are implanted annually, various well-known difficulties are present.


The pulse generator, when located subcutaneously, presents a bulge in the skin that patients can find unsightly or unpleasant. Patients can manipulate or “twiddle” the device. Even without persistent twiddling, subcutaneous pulse generators can exhibit erosion, extrusion, infection, and disconnection, insulation damage, or conductor breakage at the wire leads. Although sub-muscular or abdominal placement can address some of concerns, such placement involves a more difficult surgical procedure for implantation and adjustment, which can prolong patient recovery.


A conventional pulse generator, whether pectoral or abdominal, has an interface for connection to and disconnection from the electrode leads that carry signals to and from the heart. Usually at least one male connector molding has at least one terminal pin at the proximal end of the electrode lead. The at least one male connector mates with at least one corresponding female connector molding and terminal block within the connector molding at the pulse generator. Usually a setscrew is threaded in at least one terminal block per electrode lead to secure the connection electrically and mechanically. One or more O-rings usually are also supplied to help maintain electrical isolation between the connector moldings. A setscrew cap or slotted cover is typically included to provide electrical insulation of the setscrew. The complex connection between connectors and leads provides multiple opportunities for malfunction.


For example, failure to introduce the lead pin completely into the terminal block can prevent proper connection between the generator and electrode.


Failure to insert a screwdriver correctly through the setscrew slot, causing damage to the slot and subsequent insulation failure.


Failure to engage the screwdriver correctly in the setscrew can cause damage to the setscrew and preventing proper connection.


Failure to tighten the setscrew adequately also can prevent proper connection between the generator and electrode, however over-tightening of the setscrew can cause damage to the setscrew, terminal block, or lead pin, and prevent disconnection if necessary for maintenance.


Fluid leakage between the lead and generator connector moldings, or at the setscrew cover, can prevent proper electrical isolation.


Insulation or conductor breakage at a mechanical stress concentration point where the lead leaves the generator can also cause failure.


Inadvertent mechanical damage to the attachment of the connector molding to the generator can result in leakage or even detachment of the molding.


Inadvertent mechanical damage to the attachment of the connector molding to the lead body, or of the terminal pin to the lead conductor, can result in leakage, an open -circuit condition, or even detachment of the terminal pin and/or molding.


The lead body can be cut inadvertently during surgery by a tool, or cut after surgery by repeated stress on a ligature used to hold the lead body in position. Repeated movement for hundreds of millions of cardiac cycles can cause lead conductor breakage or insulation damage anywhere along the lead body.


Although leads are available commercially in various lengths, in some conditions excess lead length in a patient exists and is to be managed. Usually the excess lead is coiled near the pulse generator. Repeated abrasion between the lead body and the generator due to lead coiling can result in insulation damage to the lead.


Friction of the lead against the clavicle and the first rib, known as subclavian crush, can result in damage to the lead.


In many applications, such as dual-chamber pacing, multiple leads can be implanted in the same patient and sometimes in the same vessel. Abrasion between the leads for hundreds of millions of cardiac cycles can cause insulation breakdown or even conductor failure.


Communication between the implanted pulse generator and external programmer uses a telemetry coil or antenna and associated circuitry in the pulse generator, adding complexity that increases the size and cost of devices. Moreover, power consumption from the pulse generator battery for communication typically exceeds power for pacing by one or more orders of magnitude, introducing a requirement for battery power capability that can prevent selecting the most optimal battery construction for the otherwise low-power requirements of pacing.


SUMMARY

According to an embodiment of a biostimulation system, a leadless cardiac pacemaker comprises a housing, a plurality of electrodes coupled to an outer surface of the housing, and a pulse delivery system hermetically contained within the housing and electrically coupled to the electrode plurality, the pulse delivery system configured for sourcing energy internal to the housing, generating and delivering electrical pulses to the electrode plurality. The pacemaker further comprises an activity sensor hermetically contained within the housing and adapted to sense activity and a processor hermetically contained within the housing and communicatively coupled to the pulse delivery system, the activity sensor, and the electrode plurality, the processor configured to control electrical pulse delivery at least partly based on the sensed activity.





BRIEF DESCRIPTION OF THE DRAWINGS

Embodiments of the invention relating to both structure and method of operation may best be understood by referring to the following description and accompanying drawings, in which similar reference characters denote similar elements throughout the several views:



FIG. 1A is a pictorial diagram showing an embodiment of a cardiac pacing system that includes a rate-responsive leadless cardiac pacemaker;



FIG. 1B is a schematic block diagram showing interconnection of operating elements of an embodiment of the illustrative rate-responsive leadless cardiac pacemaker;



FIG. 2 is a pictorial diagram showing the physical location of some elements of an embodiment of a rate-responsive leadless cardiac pacemaker;



FIG. 3 is a pictorial diagram that depicts the physical location of some elements in an alternative embodiment of a rate-responsive leadless cardiac pacemaker;



FIG. 4 is a time waveform graph illustrating a conventional pacing pulse;



FIG. 5 is a time waveform graph depicting a pacing pulse adapted for communication as implemented for an embodiment of the illustrative pacing system;



FIG. 6 is a time waveform graph showing a sample pulse waveform using off-time variation for communication;



FIG. 7 is a schematic flow chart depicting an embodiment of a method for operating an activity sensor in a rate-responsive cardiac pacemaker; and



FIG. 8 is a schematic flow chart showing an embodiment of a method for communicating information for setting control parameters for an activity sensor in a cardiac pacing system.





DETAILED DESCRIPTION

In an illustrative system, a rate-responsive leadless cardiac pacemaker can be implanted adjacent to the inside or outside wall of a cardiac chamber.


In addition, a technique for rate-responsive pacing enables pacing control of the leadless cardiac pacemaker which is implanted adjacent to the inside or outside wall of a cardiac chamber.


A cardiac pacemaker for implantation in the human body, more specifically a leadless cardiac pacemaker for implantation adjacent to the inside or outside wall of a cardiac chamber, uses two or more electrodes located within, on, or within two centimeters of the housing of the pacemaker for pacing and sensing at the cardiac chamber and for bidirectional communication with at least one other device within or outside the body. The pacemaker contains an activity sensor, such as an accelerometer, temperature sensor, and/or a pressure transducer to measure patient activity, enabling rate-responsive pacing.


The illustrative system enables cardiac pacing without a pulse generator located in the pectoral region or abdomen, without an electrode-lead separate from the pulse generator, without a communication coil or antenna, and without an additional requirement on battery power for transmitted communication.


An illustrative rate-responsive leadless cardiac pacemaker can be substantially enclosed in a hermetic housing suitable for placement on or attachment to the inside or outside of a cardiac chamber. The pacemaker has at least two electrodes located within, on, or near the housing, for delivering pacing pulses to and sensing electrical activity from the muscle of the cardiac chamber, and for bidirectional communication with at least one other device within or outside the body. The housing contains a primary battery to provide power for pacing, sensing, and communication. The housing also contains circuits for sensing cardiac activity from the electrodes, receiving information from at least one other device via the electrodes, generating pacing pulses for delivery via the electrodes, transmitting information to at least one other device via the electrodes, monitoring device health, and controlling these operations in a predetermined manner.


A leadless pacemaker is configured for implantation adjacent to the inside or outside wall of a cardiac chamber, without the need for a connection between the pulse generator and electrode lead, and without the need for a lead body.


In some embodiments, the illustrative system enables communication between the implanted pulse generator and a device internal or external to the body, using conducted communication via the same electrodes used for pacing, without the need for an antenna or telemetry coil.


Still other embodiments enable communication between the implanted pulse generator and a device internal or external to the body, with power consumption similar to that for cardiac pacing, to allow optimization of battery performance.


Referring to FIGS. 1A and 1B, a pictorial view which is not shown to scale and a schematic block diagram respectively depict an embodiment of a cardiac pacing system 100 that comprises a rate-responsive leadless cardiac pacemaker 102. The rate-responsive leadless cardiac pacemaker 102 comprises a housing 110, multiple electrodes 108 coupled to the housing 110, a pulse delivery system 152 hermetically contained within the housing 110 and electrically coupled to the electrodes 108. The pulse delivery system 152 configured for sourcing energy internal to the housing 110, generating and delivering electrical pulses to the electrodes 108. The rate-responsive leadless cardiac pacemaker 102 further comprises an activity sensor 154 which is hermetically contained within the housing 110 and adapted to sense activity. A processor 112 is also hermetically contained within the housing 110 as part of a pulse delivery system 152 and is communicatively coupled to the activity sensor 154, and the electrodes 108. The processor 112 can control electrical pulse delivery at least partly based on the sensed activity.


In various embodiments, the electrodes 108 can be coupled on, within, or within two centimeters of the housing 110. In some arrangements, the electrodes 108 can be formed integrally to an outer surface of the housing 110.


Referring to FIG. 1B, the rate-responsive leadless cardiac pacemaker 102 has functional elements substantially enclosed in a hermetic housing 110. The pacemaker has at least two electrodes 108 located within, on, or near the housing 110, for delivering pacing pulses to and sensing electrical activity from the muscle of the cardiac chamber, and for bidirectional communication with at least one other device within or outside the body. Hermetic feedthroughs 130, 131 conduct electrode signals through the housing 110. The housing 110 contains a primary battery 114 to provide power for pacing, sensing, and communication. The housing 110 contains circuits 132 for sensing cardiac activity from the electrodes 108; circuits 134 for receiving information from at least one other device via the electrodes 108; and a pulse generator 116 for generating pacing pulses for delivery via the electrodes 108 and also for transmitting information to at least one other device via the electrodes 108. The pacemaker 102 further contains circuits for monitoring device health, for example a battery current monitor 136 and a battery voltage monitor 138. The pacemaker 102 further contains processor or controller circuits 112 for controlling these operations in a predetermined manner.


In accordance with another embodiment of a pacing system, a leadless cardiac pacemaker 102 comprises a housing 110, multiple electrodes 108 coupled to the housing 108, and a pulse generator 116 hermetically contained within the housing 110 and electrically coupled to the electrodes 108. The pulse generator 116 is configured to generate and deliver electrical pulses to the electrodes 108 powered from a source 114 contained entirely within the housing 110. An activity sensor 154 is hermetically contained within the housing 110 and adapted to sense activity. A logic 112, for example a processor, controller, central processing unit, state machine, programmable logic array, and the like, which is hermetically contained within the housing 110 and communicatively coupled to the pulse generator 116, the activity sensor 154, and the electrodes 108. The logic 112 is configured to control electrical pulse delivery at least partly based on the sensed activity.


In some embodiments, the logic 112 can be a processor that controls electrical pulse delivery and application of the activity sensor according to one or more programmable parameters with the processor programmable by communication signals transmitted via the electrodes 108.


The information communicated on the incoming communication channel can include, but is not limited to pacing rate, pulse duration, sensing threshold, and other parameters commonly programmed externally in typical pacemakers. The information communicated on the outgoing communication channel can include, but is not limited to programmable parameter settings, event counts (pacing and sensing), battery voltage, battery current, and other information commonly displayed by external programmers used with common pacemakers. The outgoing communication channel can also echo information from the incoming channel, to confirm correct programming.


Also shown in FIG. 1B, the primary battery 114 has positive terminal 140 and negative terminal 142. A suitable primary battery has an energy density of at least 3 W·h/cc, a power output of 70 microwatts, a volume less than 1 cubic centimeter, and a lifetime greater than 5 years.


One suitable primary battery uses beta-voltaic technology, licensed to BetaBatt Inc. of Houston, Tex., USA, and developed under a trade name DEC™ Cell, in which a silicon wafer captures electrons emitted by a radioactive gas such as tritium. The wafer is etched in a three-dimensional surface to capture more electrons. The battery is sealed in a hermetic package which entirely contains the low-energy particles emitted by tritium, rendering the battery safe for long-term human implant from a radiological-health standpoint. Tritium has a half-life of 12.3 years so that the technology is more than adequate to meet a design goal of a lifetime exceeding 5 years.


In accordance with another embodiment of a pacing system, a leadless cardiac pacemaker 102 comprises a housing 110, multiple electrodes 108 coupled to the housing 110, and a pulse generator 116 hermetically contained within the housing 110 and electrically coupled to the electrodes 108. The pulse generator 116 generates and delivers electrical pulses to the electrodes 108, causing cardiac contractions. The pulse generator 116 also conveys information to one or more devices 106 external to the pacemaker 102. The pacemaker 102 further comprises at least one amplifier 132, 134 hermetically contained within the housing 110 and electrically coupled to the electrodes 108. The amplifier or amplifiers 132, 134 are configured to amplify signals received from the electrodes 108 and to detect cardiac contractions, and further can receive information from the external device or devices 106. The pacemaker 102 further comprises a power supply 114 hermetically contained within the housing 110 and coupled to the pulse generator 116. The power supply 114 sources energy for the electrical pulses from internal to the housing 110. The pacemaker 102 has an activity sensor 154 hermetically contained within the housing 110 that senses activity. A processor 112 is hermetically contained within the housing 110 and communicatively coupled to the pulse generator 116, the amplifiers 132, 134, the activity sensor 154, and the electrodes 108. The processor 112 configured to receive amplifier output signals from the amplifier or amplifiers 132, 134 and control electrical pulse delivery at least partly based on the sensed activity.


In an illustrative embodiment, the amplifiers comprise a cardiac sensing amplifier 132 that consumes no more than 5 microwatts, a communications amplifier 134 that consumes no more than 25 microwatts, and a rate-response sensor amplifier 156 that consumes no more than 10 microwatts.


In an example embodiment, the regulator 146 can be configured to consume electrical power of no more than 2 microwatts and configured to supply electrical power of no more than 74 microwatts in the illustrative system that includes a rate-response amplifier.


The processor 112 can be configured to consume electrical power of no more than 5 microwatts averaged over one cardiac cycle.


Current from the positive terminal 140 of primary battery 114 flows through a shunt 144 to a regulator circuit 146 to create a positive voltage supply 148 suitable for powering the remaining circuitry of the pacemaker 102. The shunt 144 enables the battery current monitor 136 to provide the processor 112 with an indication of battery current drain and indirectly of device health.


The illustrative power supply can be a primary battery 114 such as a beta-voltaic converter that obtains electrical energy from radioactivity. In some embodiments, the power supply can be selected as a primary battery 114 that has a volume less than approximately 1 cubic centimeter.


In an illustrative embodiment, the primary battery 114 can be selected to source no more than 75-80 microwatts instantaneously since a higher consumption may cause the voltage across the battery terminals to collapse. Accordingly in one illustrative embodiment the circuits depicted in FIG. 1B can be designed to consume no more than a total of 74 microwatts. The design avoids usage of a large filtering capacitor for the power supply or other accumulators such as a supercapacitor or rechargeable secondary cell to supply peak power exceeding the maximum instantaneous power capability of the battery, components that would add volume and cost.


In various embodiments, the system can manage power consumption to draw limited power from the battery, thereby reducing device volume. Each circuit in the system can be designed to avoid large peak currents. For example, cardiac pacing can be achieved by discharging a tank capacitor (not shown) across the pacing electrodes. Recharging of the tank capacitor is typically controlled by a charge pump circuit. In a particular embodiment, the charge pump circuit is throttled to recharge the tank capacitor at constant power from the battery.


Implantable systems that communicate via long distance radio-frequency (RF) schemes, for example Medical Implant Communication Service (MICS) transceivers, which exhibit a peak power requirement on the order of 10 milliwatts, and other RF or inductive telemetry schemes are unable to operate without use of an additional accumulator. Moreover, even with the added accumulator, sustained operation would ultimately cause the voltage across the battery to collapse.


In various embodiments, the activity sensor 154 is adapted for controlling rate-responsive pacing and may use any appropriate technology, for the example the activity sensor 154 may be an accelerometer, a temperature sensor, a pressure sensor, or any other suitable sensor.


In an illustrative embodiment, the activity sensor 154 can operate with a power requirement of no more than 10 microwatts.



FIG. 1B shows a pacemaker embodiment wherein the activity sensor comprises an accelerometer 154 and an accelerometer amplifier 156 configured to detect patient activity for rate-responsive pacing. The accelerometer amplifier output terminal is connected to the processor 112. Because the leadless cardiac pacemaker 102 is attached to cardiac muscle 104, the accelerometer 154 measures some acceleration due to heartbeats in addition to the desired activity signal. Processor 112 performs sampling of the accelerometer output signal synchronously with the cardiac cycle as determined by the cardiac sensing amplifier 132 and the pulse generator 116. Processor 112 then compares acceleration signals taken at the same relative time in multiple cardiac cycles to distinguish the part of the acceleration signal that results from activity and is not due to heart wall motion.


In other embodiments, the accelerometer 154 and accelerometer amplifier 156 shown in FIG. 1B can be replaced with a temperature transducer such as a thermistor and a signal conditioning amplifier connected to processor 112. In another embodiment, a pressure transducer and signal conditioning amplifier can be connected to processor 112. Temperature is not sensitive to the cardiac cycle so that in such an activity sensor rate-responsive cardiac pacemaker embodiments, synchronous sampling with the cardiac cycle is superfluous. Although pressure varies in the cardiac cycle, easily measured features of the pressure wave, for example peak amplitude, peak-to-peak amplitude, peak rate of change (delta), and the like, can indicate the level of activity.


Also shown in FIG. 2, a cylindrical hermetic housing 110 is shown with annular electrodes 108 at housing extremities. In the illustrative embodiment, the housing 110 can be composed of alumina ceramic which provides insulation between the electrodes. The electrodes 108 are deposited on the ceramic, and are platinum or platinum-iridium.


Several techniques and structures can be used for attaching the housing 110 to the interior or exterior wall of cardiac muscle 104.


A helix 226 and slot 228 enable insertion of the device endocardially or epicardially through a guiding catheter. A screwdriver stylet can be used to rotate the housing 110 and force the helix 226 into muscle 104, thus affixing the electrode 108A in contact with stimulable tissue. Electrode 108B serves as an indifferent electrode for sensing and pacing. The helix 226 may be coated for electrical insulation, and a steroid-eluting matrix may be included near the helix to minimize fibrotic reaction, as is known in conventional pacing electrode-leads.


In other configurations, suture holes 224 and 225 can be used to affix the device directly to cardiac muscle with ligatures, during procedures where the exterior surface of the heart can be accessed.


The leadless cardiac pacemaker or pacemakers 102 can be configured to detect a natural cardiac depolarization, time a selected delay interval, and deliver an information-encoded pulse during a refractory period following the natural cardiac depolarization. By encoding information in a pacing pulse, power consumed for transmitting information is not significantly greater than the power used for pacing. Information can be transmitted through the communication channel with no separate antenna or telemetry coil. Communication bandwidth is low with only a small number of bits encoded on each pulse.


In some embodiments, information can be encoded using a technique of gating the pacing pulse for very short periods of time at specific points in the pacing pulse. During the gated sections of the pulse, no current flows through the electrodes of a leadless cardiac pacemaker. Timing of the gated sections can be used to encode information. The specific length of a gated segment depends on the programmer's ability to detect the gated section. A certain amount of smoothing or low-pass filtering of the signal can be expected from capacitance inherent in the electrode/skin interface of the programmer as well as the electrode/tissue interface of the leadless cardiac pacemaker. A gated segment is set sufficiently long in duration to enable accurate detection by the programmer, limiting the amount of information that can be transmitted during a single pacing pulse. Accordingly, a technique for communication can comprise generating stimulation pulses on stimulating electrodes of an implanted biostimulator and encoding information onto generated stimulation pulses. Encoding information onto the pulses can comprise gating the stimulation pulses for selected durations at selected timed sections in the stimulation pulses whereby gating removes current flow through the stimulating electrodes and timing of the gated sections encodes the information.


Another method of encoding information on pacing pulses involves varying the timing between consecutive pacing pulses in a pulse sequence. Pacing pulses, unless inhibited or triggered, occur at predetermined intervals. The interval between any two pulses can be varied slightly to impart information on the pulse series. The amount of information, in bits, is determined by the time resolution of the pulse shift. The steps of pulse shifting are generally on the order of microseconds. Shifting pulses by up to several milliseconds does not have an effect on the pacing therapy and cannot be sensed by the patient, yet significant information can be transmitted by varying pulse intervals within the microsecond range. The method of encoding information in variation of pulses is less effective if many of the pulses are inhibited or triggered. Accordingly, a technique for communication can comprise generating stimulation pulses on stimulating electrodes of an implanted biostimulator and encoding information onto generated stimulation pulses comprising selectively varying timing between consecutive stimulation pulses.


Alternatively or in addition to encoding information in gated sections and/or pulse interval, overall pacing pulse width can be used to encode information.


The three described methods of encoding information on pacing pulses can use the programmer to distinguish pacing pulses from the patient's normal electrocardiogram, for example by recognition of the specific morphology of the pacing pulse compared to the R-wave generated during the cardiac cycle. For example, the external programmer can be adapted to distinguish a generated cardiac pacing pulse from a natural cardiac depolarization in an electrocardiogram by performing comparative pattern recognition of a pacing pulse and an R-wave produced during a cardiac cycle.


Other attachment structures used with conventional cardiac electrode-leads including tines or barbs for grasping trabeculae in the interior of the ventricle, atrium, or coronary sinus may also be used in conjunction with or instead of the illustrative attachment structures.


Referring to FIG. 3, a pictorial view shows another embodiment of a pulse generator that includes a cylindrical metal housing 310 with an annular electrode 108A and a second electrode 108B. Housing 310 can be constructed from titanium or stainless steel. Electrode 108A can be constructed using a platinum or platinum-iridium wire and a ceramic or glass feed-thru to provide electrical isolation from the metal housing. The housing can be coated with a biocompatible polymer such as medical grade silicone or polyurethane except for the region outlined by electrode 108B. The distance between electrodes 108A and 108B should be selected to optimize sensing amplitudes and pacing thresholds. A helix 226 and slot 228 can be used for insertion of the device endocardially or epicardially through a guiding catheter. In addition, suture sleeves 302 and 303 made from silicone can be used to affix to the device directly to cardiac muscle with ligatures.


In accordance with another embodiment of a pacing system 100, a pacemaker configured as a rate-responsive leadless cardiac pacemaker 102 comprising a housing 110, and multiple electrodes 108 coupled to the housing 110. A pulse generator 116 hermetically contained within the housing 110 and electrically coupled to the electrodes 108 and is configured for generating and delivering electrical pulses to the electrodes 108. An activity sensor 154 is hermetically contained within the housing 110 and adapted to sense activity. A processor 112 is hermetically contained within the housing and communicatively coupled to the pulse generator 116, the activity sensor 154, and the electrodes 108. The processor 112 controls electrical pulse delivery at least partly based on the sensed activity and communicates with one or more devices 106 external to the pacemaker 102 via signals conducted through the electrodes 108.


In various embodiments, the processor 112 and pulse delivery system 152 transmits and/or receives information such as programmable parameter settings, event counts, power-supply voltage, power-supply current, rate-response control parameters adapted for converting an activity sensor signal to a rate-responsive pacing parameter.


Referring to FIG. 4, a typical output-pulse waveform for a conventional pacemaker is shown. The approximately-exponential decay is due to discharge of a capacitor in the pacemaker through the approximately-resistive load presented by the electrodes/tissue interface and leads. Typically the generator output is capacitor-coupled to one electrode to ensure net charge balance. The pulse duration is shown as T0 and is typically 500 microseconds.


When the pacemaker 102 is supplying a pacing pulse but is not sending data for communication, the waveform can resemble that shown in FIG. 4.


In some embodiments, configurations, or conditions, the processor 112 and pulse delivery system 152 are configured to generate and deliver electrical energy with the stimulation pulse interrupted by at least one notch that conveys information to a device 106 external to the pacemaker 102.


Referring to FIG. 5, a time waveform graph depicts an embodiment of a sample output-pacing pulse waveform adapted for communication. The output-pulse waveform of the illustrative leadless pacemaker 102 is shown during a time when the pacemaker 102 is sending data for communication and also delivering a pacing pulse, using the same pulse generator 116 and electrodes 108 for both functions.



FIG. 5 shows that the pulse generator 102 has divided the output pulse into shorter pulses 501, 502, 503, 504; separated by notches 505, 506, and 507. The pulse generator 102 times the notches 505, 506, and 507 to fall in timing windows W1, W2, and W4 designated 508, 509, and 511 respectively. Note that the pacemaker 102 does not form a notch in timing window W3 designated 510. The timing windows are each shown separated by a time T1, approximately 100 microseconds in the example.


As controlled by processor 112, pulse generator 116 selectively generates or does not generate a notch in each timing window 508, 509, 510, and 511 so that the device 102 encodes four bits of information in the pacing pulse. A similar scheme with more timing windows can send more or fewer bits per pacing pulse. The width of the notches is small, for example approximately 15 microseconds, so that the delivered charge and overall pulse width, specifically the sum of the widths of the shorter pulses, in the pacing pulse is substantially unchanged from that shown in FIG. 4. Accordingly, the pulse shown in FIG. 5 can have approximately the same pacing effectiveness as that shown in FIG. 4, according to the law of Lapique which is well known in the art of electrical stimulation.


In a leadless cardiac pacemaker, a technique can be used to conserve power when detecting information carried on pacing pulses from other implanted devices. The leadless cardiac pacemaker can have a receiving amplifier that implements multiple gain settings and uses a low-gain setting for normal operation. The low-gain setting could be insufficiently sensitive to decode gated information on a pacing pulse accurately but could detect whether the pacing pulse is present. If an edge of a pacing pulse is detected during low-gain operation, the amplifier can be switched quickly to the high-gain setting, enabling the detailed encoded data to be detected and decoded accurately. Once the pacing pulse has ended, the receiving amplifier can be set back to the low-gain setting. For usage in the decoding operation, the receiving amplifier is configured to shift to the more accurate high-gain setting quickly when activated. Encoded data can be placed at the end of the pacing pulse to allow a maximum amount of time to invoke the high-gain setting.


In some embodiments, configurations, or conditions, the processor 112 and pulse delivery system 152 are configured to generate and deliver electrical energy with the stimulation pulse that conveys information to a device 106 external to the pacemaker 102 in designated codes encoding the information in modulation of off-time between pacing pulses.


As an alternative or in addition to using notches in the stimulation pulse, the pulses can be generated with varying off-times, specifically times between pulses during which no stimulation occurs. The variation of off-times can be small, for example less than 10 milliseconds total, and can impart information based on the difference between a specific pulse's off-time and a preprogrammed off-time based on desired heart rate. For example, the device can impart four bits of information with each pulse by defining 16 off-times centered around the preprogrammed off-time. FIG. 6 is a graph showing a sample pulse generator output which incorporates a varying off-time scheme. In the figure, time TP represents the preprogrammed pulse timing. Time Td is the delta time associated with a single bit resolution for the data sent by the pulse generator. The number of Td time increments before or after the moment specified by TP gives the specific data element transmitted. The receiver of the pulse generator's communication has advance information of the time TP. The communication scheme is primarily applicable to overdrive pacing in which time TP is not changing based on detected beats.


In some embodiments, configurations, or conditions, the processor 112 and pulse delivery system 152 are configured to generate and deliver electrical energy with the stimulation pulse that conveys information to a device 106 external to the pacemaker 102 in designated codes encoding the information in pacing pulse width.



FIG. 5 depicts a technique in which information is encoded in notches in the pacing pulse. FIG. 6 shows a technique of conveying information by modulating the off-time between pacing pulses. Alternatively or in addition to the two illustrative coding schemes, overall pacing pulse width can be used to impart information. For example, a paced atrial beat may exhibit a pulse width of 500 microseconds and an intrinsic atrial contraction can be identified by reducing the pulse width by 30 microseconds. Information can be encoded by the absolute pacing pulse width or relative shift in pulse width. Variations in pacing pulse width can be relatively small and have no impact on pacing effectiveness.


To ensure the leadless cardiac pacemaker functions correctly, a specific minimum internal supply voltage is maintained. When pacing tank capacitor charging occurs, the supply voltage can drop from a pre-charging level which can become more significant when the battery nears an end-of-life condition and has reduced current sourcing capability. Therefore, a leadless cardiac pacemaker can be constructed with a capability to stop charging the pacing tank capacitor when the supply voltage drops below a specified level. When charging ceases, the supply voltage returns to the value prior to the beginning of tank capacitor charging.


In another technique, the charge current can be lowered to prevent the supply voltage from dropping below the specified level. However, lowering the charge current can create difficulty in ensuring pacing rate or pacing pulse amplitude are maintained, since the lower charge current can extend the time for the pacing tank capacitor to reach a target voltage level.


The illustrative scheme for transmitting data does not significantly increase the current consumption of the pacemaker. For example, the pacemaker could transmit data continuously in a loop, with no consumption penalty.


The illustrative example avoids usage of radiofrequency (RF) communication to send pacing instructions to remote electrodes on a beat-to-beat basis to cause the remote electrodes to emit a pacing pulse. RF communication involves use of an antenna and modulation/demodulation unit in the remote electrode, which increase implant size significantly. Also, communication of pacing instructions on a beat-to-beat basis increases power requirements for the main body and the remote electrode. In contrast, the illustrative system and stimulator do not require beat-to-beat communication with any controlling main body.


The illustrative leadless pacemaker 102 includes an internal power source that can supply all energy for operations and pulse generation. In contrast, some conventional implanted pulse generators have remote pacing electrodes that receive some or all energy from an energy source through an RF induction technique, an energy transfer scheme that employs a large loop antenna on the remote electrode which increases size significantly. In addition, energy transfer with the RF induction technique is inefficient and is associated with a significant increase in battery size of the energy source. In contrast, the illustrative leadless pacemaker 102 uses an internal battery and does not require energy to be drawn from outside sources. Also in the conventional system, the energy source receives sensing information by RF communication from the remote electrodes and sends pacing instructions to the electrodes on a beat-to-beat basis in a configuration that uses an addressing scheme in which the identity of specific remote pacing electrodes is stored in the energy source memory. The conventional method can also be inefficient due to overhead for transmitting an identification number from/to a generic pacing electrode at implant and/or during sensing. The illustrative leadless pacemaker 102 avoids such overhead through a structure in which pulse generation functionality is independent within a single implantable body.


Another conventional technology uses a system of addressable remote electrodes that stimulate body tissue without requiring a main body to send commands for individual stimulations. The remote electrodes are specified to be of a size and shape suitable for injection rather than for endocardial implantation. A controller sets operating parameters and sends the parameters to remote electrodes by addressable communication, enabling the remote electrodes function relatively autonomously while incurring some overhead to controller operations. However, the remote electrodes do not sense or monitor cardiac information and rely on the main body to provide sensing functionality. In contrast, the illustrative leadless pacemaker 102 combines pacing and sensing of intrinsic cardiac activity in a single implantable body.


Referring again to FIG. 1B, the circuit 132 for receiving communication via electrodes 108 receives the triggering information as described and can also optionally receive other communication information, either from the other implanted pulse generator 106 or from a programmer outside the body. This other communication could be coded with a pulse-position scheme as described in FIG. 5 or could otherwise be a pulse-modulated or frequency-modulated carrier signal, preferably from 10 kHz to 100 kHz.


With regard to operating power requirements in the leadless cardiac pacemaker 102, for purposes of analysis, a pacing pulse of 5 volts and 5 milliamps amplitude with duration of 500 microseconds and a period of 500 milliseconds has a power requirement of 25 microwatts.


In an example embodiment of the leadless pacemaker 102, the processor 112 typically includes a timer with a slow clock that times a period of approximately 10 milliseconds and an instruction-execution clock that times a period of approximately 1 microsecond. The processor 112 typically operates the instruction-execution clock only briefly in response to events originating with the timer, communication amplifier 134, or cardiac sensing amplifier 132. At other times, only the slow clock and timer operate so that the power requirement of the processor 112 is no more than 5 microwatts.


For a pacemaker that operates with the aforementioned slow clock, the instantaneous power consumption specification, even for a commercially-available micropower microprocessor, would exceed the battery's power capabilities and would require an additional filter capacitor across the battery to prevent a drop of battery voltage below the voltage necessary to operate the circuit. The filter capacitor would add avoidable cost, volume, and potentially lower reliability.


For example, a microprocessor consuming only 100 microamps would require a filter capacitor of 5 microfarads to maintain a voltage drop of less than 0.1 volt, even if the processor operates for only 5 milliseconds. To avoid the necessity for such a filter capacitor, an illustrative embodiment of a processor can operate from a lower frequency clock to avoid the high instantaneous power consumption, or the processor can be implemented using dedicated hardware state machines to supply a lower instantaneous peak power specification.


In a pacemaker, the cardiac sensing amplifier typically operates with no more than 5 microwatts.


An accelerometer amplifier, or other general purpose signal conditioning amplifier, operates with approximately 10 microwatts.


A communication amplifier at 100 kHz operates with no more than 25 microwatts. The battery ammeter and battery voltmeter operate with no more than 1 microwatt each.


A pulse generator typically includes an independent rate limiter with a power consumption of no more than 2 microwatts.


The total power consumption of the pacemaker is thus 74 microwatts, less than the disclosed 75-microwatt battery output.


Improvement attained by the illustrative cardiac pacing system 100 and leadless cardiac pacemaker 102 is apparent.


The illustrative cardiac pacing system 100 enables encoding optional outgoing communication in the pacing pulse, so that the outgoing communication power requirement does not exceed the pacing current requirement, approximately 25 microwatts.


The illustrative leadless cardiac pacemaker 102 can have sensing and processing circuitry that consumes no more than 10 microwatts as in conventional pacemakers.


The described leadless cardiac pacemaker 102 can have an incoming communication amplifier for receiving triggering signals and optionally other communication which consumes no more than 25 microwatts.


Furthermore, the leadless cardiac pacemaker 102 can have a primary battery that exhibits an energy density of at least 3 watt-hours per cubic centimeter (W·h/cc).


Referring to FIG. 7, a schematic flow chart depicts an embodiment of a method 700 for operating an activity sensor in a rate-responsive cardiac pacemaker. A leadless cardiac pacemaker that includes a rate-response sensor is implanted 702 in contact with cardiac muscle. An activity signal is measured 704 using the rate-response sensor. The activity signal includes an artifact signal that results from cardiac muscle motion. The activity signal is sampled 706 synchronously with a cardiac cycle. The activity signal is monitored 708 at identified points in the cardiac cycle. The artifact signal is removed 710 from the activity signal based on the monitoring. In various embodiments, the activity signal can be measured using an accelerator, thermistor, or pressure sensor.


Referring to FIG. 8, a schematic flow chart depicts an embodiment of a method 800 for setting operating parameters in a rate-responsive cardiac pacemaker. The method 800 comprises sensing 802 electrical signals conducted through a patient's body, decoding 804 information encoded in the electrical signals, and storing the result. An activity signal is sensed 806 within the pacemaker. The activity sensor signal is converted 808 to a rate-responsive pacing parameter as a function of the stored information encoded in the electrical signals. Pacing pulse delivery is controlled 810 as a function of the rate-responsive pacing parameter.


In some embodiments, information is encoded, for example, as a binary code in one or more notches interrupting a stimulation pulse. Information can otherwise or also be encoded in selected or designated codes as variations in pacing pulse width of a stimulation pulse. Information can also be conveyed as electrical energy in a stimulation pulse in designated codes encoding the information in modulation of off-time between pacing pulses.


Terms “substantially”, “essentially”, or “approximately”, that may be used herein, relate to an industry-accepted tolerance to the corresponding term. Such an industry-accepted tolerance ranges from less than one percent to twenty percent and corresponds to, but is not limited to, component values, integrated circuit process variations, temperature variations, rise and fall times, and/or thermal noise. The term “coupled”, as may be used herein, includes direct coupling and indirect coupling via another component, element, circuit, or module where, for indirect coupling, the intervening component, element, circuit, or module does not modify the information of a signal but may adjust its current level, voltage level, and/or power level. Inferred coupling, for example where one element is coupled to another element by inference, includes direct and indirect coupling between two elements in the same manner as “coupled”.


While the present disclosure describes various embodiments, these embodiments are to be understood as illustrative and do not limit the claim scope. Many variations, modifications, additions and improvements of the described embodiments are possible. For example, those having ordinary skill in the art will readily implement the steps necessary to provide the structures and methods disclosed herein, and will understand that the process parameters, materials, and dimensions are given by way of example only. The parameters, materials, and dimensions can be varied to achieve the desired structure as well as modifications, which are within the scope of the claims. Variations and modifications of the embodiments disclosed herein may also be made while remaining within the scope of the following claims. For example, although the description has some focus on CRT, the pacemaker, system, structures, and techniques can otherwise be applicable to other uses, for example multi-site pacing for prevention of tachycardias in the atria or ventricles. Phraseology and terminology employed herein are for the purpose of the description and should not be regarded as limiting. With respect to the description, optimum dimensional relationships for the component parts are to include variations in size, materials, shape, form, function and manner of operation, assembly and use that are deemed readily apparent and obvious to one of ordinary skill in the art and all equivalent relationships to those illustrated in the drawings and described in the specification are intended to be encompassed by the present description. Therefore, the foregoing is considered as illustrative only of the principles of structure and operation. Numerous modifications and changes will readily occur to those of ordinary skill in the art whereby the scope is not limited to the exact construction and operation shown and described, and accordingly, all suitable modifications and equivalents may be included.

Claims
  • 1. A pacemaker comprising: the pacemaker configured as a leadless cardiac pacemaker comprising:a housing;a plurality of electrodes coupled to the housing;a pulse delivery system hermetically contained within the housing and electrically coupled to the electrode plurality, the pulse delivery system configured for sourcing energy internal to the housing comprising a pulse generator that generates electrical pulses operative for cardiac stimulation by the plurality of electrodes and encoded for conveying information signals to a device external to the pacemaker by the plurality of electrodes;an activity sensor hermetically contained within the housing and adapted to sense activity; and a processor hermetically contained within the housing andcommunicatively coupled to the pulse delivery system, the activity sensor, and the electrode plurality, the processor configured to control leadless electrical pulse delivery at least partly based on the sensed activity.
  • 2. The pacemaker according to claim 1 wherein: the plurality of electrodes is configured for delivering stimulation pulses to cardiac tissue and coupled on, within, or within two centimeters of the housing.
  • 3. The pacemaker according to claim 1 wherein: the processor controls electrical pulse delivery and application of the activity sensor according to at least one programmable parameter, the processor being programmable by communication signals received via the plurality of electrodes.
  • 4. The pacemaker according to claim 1 further comprising: the activity sensor adapted for controlling rate-responsive pacing and selected from a group consisting of an accelerometer, a temperature sensor, and a pressure sensor.
  • 5. The pacemaker according to claim 1 wherein: the activity sensor comprises an accelerometer and accelerometer amplifier configured to detect patient activity for rate-responsive pacing.
  • 6. The pacemaker according to claim 5 further comprising: the processor configured to sample signals from the accelerometer synchronously with a cardiac cycle determined by the pulse delivery system, compare acceleration signals acquired at relative times in multiple cardiac cycles, and distinguishes acceleration signals resulting from activity from signals resulting from cardiac wall motion.
  • 7. The pacemaker according to claim 1 wherein: the activity sensor operates with a power requirement of no more than 10 Microwatts.
  • 8. The pacemaker according to claim 1 wherein: the pulse delivery system is configured for generating and delivering electrical energy in at least one pulse generated by the pulse generator and transmitted by the plurality of electrodes that conveys information to a device external to the pacemaker, wherein the information comprises data selected from a group consisting of programmable parameter settings, event counts, power-supply voltage, power-supply current, rate-response control parameters adapted for converting an activity sensor signal to a rate-responsive pacing parameter.
  • 9. The pacemaker according to claim 1 wherein: the pulse delivery system configured for generating and delivering electrical energy with at least one pulse generated by the pulse generator and transmitted by the plurality of electrodes that conveys information to a device external to the pacemaker in designated codes encoding the information in pacing pulse width, wherein the information comprises data selected from a group consisting of programmable parameter settings, event counts, power-supply voltage, power-supply current, rate-response control parameters adapted for converting an activity sensor signal to a rate-responsive pacing parameter.
  • 10. The pacemaker according to claim 1 wherein: the pulse delivery system configured for generating and delivering electrical energy with at least one pulse generated by the pulse generator and transmitted by the plurality of electrodes that conveys information to a device external to the pacemaker in designated codes encoding the information in modulation of off-time between pacing pulses, wherein the information comprises data selected from a group consisting of programmable parameter settings, event counts, power-supply voltage, power-supply current, rate-response control parameters adapted for converting an activity sensor signal to a rate-responsive pacing parameter.
  • 11. The pacemaker according to claim 1 wherein: a receiving amplifier/filter adapted for multiple controllable gain settings; wherein the processor is configured to control gain setting for the receiving amplifier/filter, invoking a low-gain setting for normal operation and detecting presence of at least one pulse, and invoking a high-gain setting for detecting and decoding information encoded in the detected at least one pulse.
  • 12. The pacemaker according to claim 1 wherein: a tank capacitor coupled across a pair of the electrode plurality and adapted for charging and discharging wherein a pacing pulse is generated; anda charge pump circuit coupled to the tank capacitor and adapted for controlling charging of the tank capacitor; wherein the processor is configured to control recharging of the tank capacitor comprising discontinuing recharging when a battery terminal voltage falls below a predetermined value to ensure sufficient voltage for powering the leadless cardiac pacemaker.
  • 13. A pacemaker comprising: the pacemaker configured as a leadless cardiac pacemaker comprising:a housing;a plurality of electrodes coupled to the housing;a pulse generator hermetically contained within the housing and electrically coupled to the electrode plurality, the pulse generator comprising a pulse generator that generates electrical pulses operative for cardiac stimulation by the plurality of electrodes and encoded for conveying information signals to a device external to the pacemaker by the plurality of electrodes;at least one amplifier hermetically contained within the housing and electrically coupled to the electrode plurality, the at least one amplifier configured to amplify signals received from the electrode plurality and amplify signals for cardiac sensing;a power supply hermetically contained within the housing and coupled to the pulse generator, the power supply configured to source energy for the electrical pulses from internal to the housing;an activity sensor hermetically contained within the housing and adapted to sense activity; and a processor hermetically contained within the housing and communicatively coupled to the pulse generator, the amplifier, the activity sensor, and the electrode plurality, the processor configured to receive amplifier output signals from the amplifier and control leadless electrical pulse delivery at least partly based on the sensed activity.
  • 14. The pacemaker according to claim 13 wherein: the plurality of electrodes is adapted for delivering stimulation pulses to cardiac tissue and is coupled on, within, or within two centimeters of the housing.
  • 15. The pacemaker according to claim 13 wherein: the processor controls electrical pulse delivery and application of the activity sensor according to at least one programmable parameter, the processor being programmable by communication signals received via the plurality of electrodes.
  • 16. The pacemaker according to claim 13 further comprising: the activity sensor adapted for controlling rate-responsive pacing and selected from a group consisting of an accelerometer, a temperature sensor, and a pressure sensor.
  • 17. The pacemaker according to claim 13 wherein: the activity sensor comprises an accelerometer and accelerometer amplifier configured to detect patient activity for rate-responsive pacing.
  • 18. The pacemaker according to claim 17 wherein: the processor is configured to sample signals from the accelerometer synchronously with a cardiac cycle determined by the pulse delivery system, compare acceleration signals acquired at relative times in multiple cardiac cycles, and distinguish acceleration signals resulting from activity from signals resulting from cardiac wall motion.
  • 19. The pacemaker according to claim 13 wherein: the activity sensor operates with a power requirement of no more than approximately 10 microwatts.
  • 20. A pacemaker comprising: the pacemaker configured as a leadless cardiac pacemaker comprising:a housing;a plurality of electrodes coupled to the housing;a pulse generator hermetically contained within the housing and electrically coupled to the electrode plurality, the pulse generator configured for generating electrical pulses and delivering the electrical pulses to the plurality of electrodes wherein cardiac contractions are stimulated, the pulse generator further configured to generate electrical pulses and deliver the electrical pulses to the plurality of electrodes wherein the electrical pulses are operative for cardiac pacing by the plurality of electrodes and encoded for conveying information signals to at least one device external to the pacemaker by the plurality of electrodes;at least one amplifier hermetically contained within the housing and electrically coupled to the electrode plurality, the at least one amplifier configured to amplify signals received from the electrode plurality and to detect cardiac contractions, the at least one amplifier further configured to receive information from the at least one external device;a power supply hermetically contained within the housing and coupled to the pulse generator, the power supply configured to source energy for the electrical pulses from internal to the housing; an activity sensor hermetically contained within the housing and adapted to sense activity; anda processor hermetically contained within the housing and communicatively coupled to the pulse generator, the at least one amplifier, the activity sensor, and the electrode plurality, the processor configured to receive amplifier output signals from the amplifier and control leadless electrical pulse delivery at least partly based on the sensed activity.
  • 21. The pacemaker according to claim 20 wherein: the plurality of electrodes is configured for delivering stimulation pulses to cardiac tissue and coupled on, within, or within two centimeters of the housing.
  • 22. The pacemaker according to claim 20 further comprising: the activity sensor adapted for controlling rate-responsive pacing and selected from a group consisting of an accelerometer, a temperature sensor, and a pressure sensor.
  • 23. The pacemaker according to claim 20 wherein: the at least one amplifier comprises a cardiac sensing amplifier that consumes no more than 5 microwatts, a communications amplifier that consumes no more than 25 microwatts, and a rate-response sensor amplifier that consumes no more than 10 microwatts.
  • 24. The pacemaker according to claim 20 wherein: the power supply is configured to consume electrical power of no more than 2 microwatts and configured to supply electrical power of no more than 74 microwatts.
  • 25. The pacemaker according to claim 20 wherein: the processor is configured to consume electrical power of no more than 5 microwatts averaged over one cardiac cycle.
  • 26. A pacemaker comprising: the pacemaker configured as a leadless cardiac pacemaker that paces cardiac tissue without usage of a lead comprising:a housing;a plurality of electrodes coupled to the housing;a pulse generator hermetically contained within the housing and electrically coupled to the electrode plurality, the pulse generator configured to generate and deliver electrical pulses to the plurality of electrodes for cardiac stimulation by the plurality of electrodes and encoded for conveying communication signals to a device external to the pacemaker by the plurality of electrodes, the pulse generator powered from a source contained entirely within the housing;an activity sensor hermetically contained within the housing and adapted to sense activity; anda logic hermetically contained within the housing and communicatively coupled to the pulse generator, the activity sensor, and the electrode plurality, the logic configured to control leadless electrical pulse delivery at least partly based on the sensed activity.
  • 27. The pacemaker according to claim 26 wherein: the plurality of electrodes is configured for delivering stimulation pulses to cardiac tissue and coupled on, within, or within two centimeters of the housing.
  • 28. A pacemaker comprising: the pacemaker configured as a leadless cardiac pacemaker that paces cardiac tissue without usage of a lead comprising: a housing;a plurality of electrodes coupled to the housing;a pulse generator hermetically contained within the housing and electrically coupled to the electrode plurality, the pulse generator configured for generating and delivering electrical pulses to the plurality of electrodes for cardiac stimulation by the plurality of electrodes and encoded for conveying communication signals to a device external to the pacemaker by the plurality of electrodes, the pulse generator;an activity sensor hermetically contained within the housing and adapted to sense activity; and a processor hermetically contained within the housing andcommunicatively coupled to the pulse generator, the activity sensor, and the electrode plurality, the processor configured to control leadless electrical pulse delivery at least partly based on the sensed activity and configured to communicate with at least one device external to the pacemaker via the electrode plurality.
  • 29. The pacemaker according to claim 28 wherein: the plurality of electrodes is configured for delivering stimulation pulses to cardiac tissue and coupled on, within, or within two centimeters of the housing.
  • 30. The pacemaker according to claim 28 wherein: the processor controls electrical pulse delivery and application of the activity sensor according to at least one programmable parameter, the processor being programmable by communication signals received via the plurality of electrodes.
  • 31. The pacemaker according to claim 28 wherein: the processor communicates to the at least one device external to the pacemaker by communication signals generated by the pulse generator and transmitted via the plurality of electrodes.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority to and incorporates herein by reference in its entirety for all purposes, Provisional U.S. Patent Application Nos. 60/726,706 entitled “LEADLESS CARDIAC PACEMAKER WITH CONDUCTED COMMUNICATION,” filed Oct. 14, 2005; 60/761,531 entitled “LEADLESS CARDIAC PACEMAKER DELIVERY SYSTEM,” filed Jan. 24, 2006; 60/729,671 entitled “LEADLESS CARDIAC PACEMAKER TRIGGERED BY CONDUCTED COMMUNICATION,” filed Oct. 24, 2005; 60/737,296 entitled “SYSTEM OF LEADLESS CARDIAC PACEMAKERS WITH CONDUCTED COMMUNICATION,” filed Nov. 16, 2005; 60/739,901 entitled “LEADLESS CARDIAC PACEMAKERS WITH CONDUCTED COMMUNICATION FOR USE WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR,” filed Nov. 26, 2005; 60/749,017 entitled “LEADLESS CARDIAC PACEMAKER WITH CONDUCTED COMMUNICATION AND RATE RESPONSIVE PACING,” filed Dec. 10, 2005; and 60/761,740 entitled “PROGRAMMER FOR A SYSTEM OF LEADLESS CARDIAC PACEMAKERS WITH CONDUCTED COMMUNICATION,” filed Jan. 24, 2006; all by Peter M. Jacobson.

US Referenced Citations (473)
Number Name Date Kind
3199508 Roth Aug 1965 A
3212496 Preston Oct 1965 A
3218638 Honig Nov 1965 A
3241556 Zacouto Mar 1966 A
3478746 Greatbatch Nov 1969 A
3603881 Thornton Sep 1971 A
3727616 Lenzkes Apr 1973 A
3757778 Graham Sep 1973 A
3823708 Lawhorn Jul 1974 A
3830228 Foner Aug 1974 A
3835864 Rasor et al. Sep 1974 A
3870051 Brindley Mar 1975 A
3872251 Auerbach et al. Mar 1975 A
3905364 Cudahy et al. Sep 1975 A
3940692 Neilson et al. Feb 1976 A
3943926 Barragan Mar 1976 A
3943936 Rasor et al. Mar 1976 A
3946744 Auerbach Mar 1976 A
3952750 Mirowski et al. Apr 1976 A
4027663 Fischler et al. Jun 1977 A
4072154 Anderson et al. Feb 1978 A
4083366 Gombrich et al. Apr 1978 A
4102344 Conway et al. Jul 1978 A
4146029 Ellinwood, Jr. Mar 1979 A
4151513 Menken et al. Apr 1979 A
4151540 Sander et al. Apr 1979 A
4152540 Duncan et al. May 1979 A
4173221 McLaughlin et al. Nov 1979 A
4187854 Hepp et al. Feb 1980 A
4210149 Heilman et al. Jul 1980 A
4223678 Langer et al. Sep 1980 A
4250888 Grosskopf Feb 1981 A
4256115 Bilitch Mar 1981 A
4296756 Dunning et al. Oct 1981 A
4310000 Lindemans Jan 1982 A
4318412 Stanly et al. Mar 1982 A
4336810 Anderson et al. Jun 1982 A
4350169 Dutcher et al. Sep 1982 A
4374382 Markowitz Feb 1983 A
4406288 Horwinski et al. Sep 1983 A
4411271 Markowitz Oct 1983 A
4418695 Buffet Dec 1983 A
4424551 Stevenson et al. Jan 1984 A
4428378 Anderson et al. Jan 1984 A
4440173 Hudziak et al. Apr 1984 A
4442840 Wojciechowicz, Jr. Apr 1984 A
4453162 Money et al. Jun 1984 A
4481950 Duggan Nov 1984 A
4513743 van Arragon et al. Apr 1985 A
4516579 Irnich May 1985 A
4522208 Buffet Jun 1985 A
4524774 Hildebrandt Jun 1985 A
4531527 Reinhold, Jr. et al. Jul 1985 A
4543955 Schroeppel Oct 1985 A
4550370 Baker Oct 1985 A
4552127 Schiff Nov 1985 A
4552154 Hartlaub Nov 1985 A
4562846 Cox et al. Jan 1986 A
4586508 Batina et al. May 1986 A
4606352 Geddes et al. Aug 1986 A
4607639 Tanagho et al. Aug 1986 A
4612934 Borkan Sep 1986 A
4625730 Fountain et al. Dec 1986 A
4679144 Cox et al. Jul 1987 A
4681111 Silvian Jul 1987 A
4681117 Brodman et al. Jul 1987 A
4702253 Nappholz et al. Oct 1987 A
4719920 Alt et al. Jan 1988 A
4722342 Amundson Feb 1988 A
4750495 Moore et al. Jun 1988 A
4763340 Yoneda et al. Aug 1988 A
4763655 Wirtzfeld et al. Aug 1988 A
4787389 Tarjan Nov 1988 A
4791931 Slate Dec 1988 A
4793353 Borkan Dec 1988 A
4794532 Leckband et al. Dec 1988 A
4802481 Schroeppel Feb 1989 A
4809697 Causey, III et al. Mar 1989 A
4827940 Mayer et al. May 1989 A
4830006 Haluska et al. May 1989 A
4844076 Lesho et al. Jul 1989 A
4846195 Alt Jul 1989 A
4860750 Frey et al. Aug 1989 A
4875483 Vollmann et al. Oct 1989 A
4880004 Baker, Jr. et al. Nov 1989 A
4883064 Olson et al. Nov 1989 A
4886064 Strandberg Dec 1989 A
4896068 Nilsson Jan 1990 A
4903701 Moore et al. Feb 1990 A
4905708 Davies Mar 1990 A
4926863 Alt May 1990 A
4987897 Funke Jan 1991 A
5010887 Thornander Apr 1991 A
5012806 De Bellis May 1991 A
5014700 Alt May 1991 A
5014701 Pless et al. May 1991 A
5031615 Alt Jul 1991 A
5040533 Fearnot Aug 1991 A
5040534 Mann et al. Aug 1991 A
5040536 Riff Aug 1991 A
5042497 Shapland Aug 1991 A
5052399 Olive et al. Oct 1991 A
5058581 Silvian Oct 1991 A
5065759 Begemann Nov 1991 A
5076270 Stutz, Jr. Dec 1991 A
5076272 Ferek-Petric Dec 1991 A
5085224 Galen et al. Feb 1992 A
5086772 Larnard et al. Feb 1992 A
5088488 Markowitz et al. Feb 1992 A
5095903 DeBellis Mar 1992 A
5109845 Yuuchi et al. May 1992 A
5111816 Pless et al. May 1992 A
5113859 Funke May 1992 A
5113869 Nappholz et al. May 1992 A
5133350 Duffin Jul 1992 A
5135004 Adams et al. Aug 1992 A
5170784 Ramon et al. Dec 1992 A
5170802 Mehra Dec 1992 A
5179947 Meyerson et al. Jan 1993 A
5184616 Weiss Feb 1993 A
5193539 Schulman et al. Mar 1993 A
5193540 Schulman et al. Mar 1993 A
5193550 Duffin Mar 1993 A
5217010 Tsitlik et al. Jun 1993 A
5247945 Heinze et al. Sep 1993 A
5259394 Bens Nov 1993 A
5267150 Wilkinson Nov 1993 A
5282841 Szyszkowski Feb 1994 A
5284136 Hauck et al. Feb 1994 A
5291902 Carman Mar 1994 A
5300093 Koestner et al. Apr 1994 A
5304206 Baker, Jr. et al. Apr 1994 A
5304209 Adams et al. Apr 1994 A
5313953 Yomtov et al. May 1994 A
5318596 Barreras et al. Jun 1994 A
5324316 Schulman et al. Jun 1994 A
5331966 Bennett et al. Jul 1994 A
5333095 Stevenson et al. Jul 1994 A
5342401 Spano et al. Aug 1994 A
5354317 Alt Oct 1994 A
5358514 Schulman et al. Oct 1994 A
5373852 Harrison et al. Dec 1994 A
5383912 Cox et al. Jan 1995 A
5383915 Adams Jan 1995 A
5404877 Nolan et al. Apr 1995 A
5405367 Schulman et al. Apr 1995 A
5406444 Selfried et al. Apr 1995 A
5411532 Mortazavi May 1995 A
5411535 Fujii et al. May 1995 A
5411537 Munshi et al. May 1995 A
5417222 Dempsey et al. May 1995 A
5419337 Dempsey et al. May 1995 A
5431171 Harrison et al. Jul 1995 A
5446447 Carney et al. Aug 1995 A
5456261 Luczyk Oct 1995 A
5466246 Silvian Nov 1995 A
5469857 Laurent et al. Nov 1995 A
5480415 Cox et al. Jan 1996 A
5481262 Urbas et al. Jan 1996 A
5522876 Rusink Jun 1996 A
5531779 Dahl et al. Jul 1996 A
5539775 Tuttle et al. Jul 1996 A
5549654 Powell Aug 1996 A
5549659 Johansen et al. Aug 1996 A
5551427 Altman Sep 1996 A
5556421 Prutchi et al. Sep 1996 A
5562717 Tippey et al. Oct 1996 A
5571143 Hoegnelid et al. Nov 1996 A
5571148 Loeb et al. Nov 1996 A
5579775 Dempsey et al. Dec 1996 A
5586556 Spivey et al. Dec 1996 A
5591217 Barreras Jan 1997 A
5598848 Swanson et al. Feb 1997 A
5649952 Lam Jul 1997 A
5650759 Hittman et al. Jul 1997 A
5654984 Hershbarger et al. Aug 1997 A
5662689 Elsberry et al. Sep 1997 A
5669391 Williams Sep 1997 A
5674259 Gray Oct 1997 A
5676153 Smith et al. Oct 1997 A
5693076 Kaemmerer Dec 1997 A
5694940 Unger et al. Dec 1997 A
5694952 Lidman et al. Dec 1997 A
5697958 Paul et al. Dec 1997 A
5702427 Ecker et al. Dec 1997 A
5725559 Alt et al. Mar 1998 A
5728154 Crossett et al. Mar 1998 A
5730143 Schwarzberg Mar 1998 A
5735880 Prutchi et al. Apr 1998 A
5738102 Lemelson Apr 1998 A
5740811 Hedberg et al. Apr 1998 A
5741314 Daly et al. Apr 1998 A
5766231 Erickson et al. Jun 1998 A
5792205 Alt et al. Aug 1998 A
5810735 Halperin et al. Sep 1998 A
5814076 Brownlee Sep 1998 A
5814087 Renirie Sep 1998 A
5814089 Stokes et al. Sep 1998 A
5824016 Ekwall Oct 1998 A
5871451 Unger et al. Feb 1999 A
5876353 Riff Mar 1999 A
5876425 Gord et al. Mar 1999 A
5891178 Mann et al. Apr 1999 A
5899928 Sholder et al. May 1999 A
5935079 Swanson et al. Aug 1999 A
5954761 Machek et al. Sep 1999 A
5957861 Combs et al. Sep 1999 A
5984861 Crowley Nov 1999 A
5987352 Klein et al. Nov 1999 A
5995876 Kruse et al. Nov 1999 A
5999857 Weijand et al. Dec 1999 A
6002969 Machek et al. Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6061596 Richmond et al. May 2000 A
6080187 Alt et al. Jun 2000 A
6093146 Filangeri Jul 2000 A
6096065 Crowley Aug 2000 A
6102874 Stone et al. Aug 2000 A
6112116 Fischell et al. Aug 2000 A
6115628 Stadler et al. Sep 2000 A
6115630 Stadler et al. Sep 2000 A
6115636 Ryan Sep 2000 A
6119031 Crowley Sep 2000 A
6125290 Miesel Sep 2000 A
6125291 Miesel et al. Sep 2000 A
6128526 Stadler et al. Oct 2000 A
6129751 Lucchesi et al. Oct 2000 A
6132390 Cookston et al. Oct 2000 A
6132456 Sommer et al. Oct 2000 A
6134459 Roberts et al. Oct 2000 A
6134470 Hartlaub Oct 2000 A
6141584 Rockwell et al. Oct 2000 A
6141588 Cox et al. Oct 2000 A
6141592 Pauly Oct 2000 A
6144866 Miesel et al. Nov 2000 A
6148230 KenKnight Nov 2000 A
6152882 Prutchi Nov 2000 A
6163723 Roberts et al. Dec 2000 A
6164284 Schulman et al. Dec 2000 A
6167310 Grevious Dec 2000 A
6178349 Kieval Jan 2001 B1
6185443 Crowley Feb 2001 B1
6185452 Schulman et al. Feb 2001 B1
6185464 Bonner et al. Feb 2001 B1
6190324 Kieval et al. Feb 2001 B1
6198952 Miesel Mar 2001 B1
6201993 Kruse et al. Mar 2001 B1
6208894 Schulman et al. Mar 2001 B1
6208900 Ecker et al. Mar 2001 B1
6223081 Kerver Apr 2001 B1
6230059 Duffin May 2001 B1
6236882 Lee et al. May 2001 B1
6240321 Janke et al. May 2001 B1
6243608 Pauly et al. Jun 2001 B1
6248080 Miesel et al. Jun 2001 B1
6263245 Snell Jul 2001 B1
6265100 Saaski et al. Jul 2001 B1
6266554 Hsu et al. Jul 2001 B1
6272379 Fischell et al. Aug 2001 B1
6280409 Stone et al. Aug 2001 B1
6289229 Crowley Sep 2001 B1
6306088 Krausman et al. Oct 2001 B1
6310960 Saaski et al. Oct 2001 B1
6315721 Schulman et al. Nov 2001 B2
6324418 Crowley et al. Nov 2001 B1
6324421 Stadler et al. Nov 2001 B1
RE37463 Altman Dec 2001 E
6343227 Crowley Jan 2002 B1
6343233 Werner et al. Jan 2002 B1
6347245 Lee et al. Feb 2002 B1
6358202 Arent Mar 2002 B1
6361522 Scheiner et al. Mar 2002 B1
6363282 Nichols et al. Mar 2002 B1
6364831 Crowley Apr 2002 B1
6381492 Rockwell et al. Apr 2002 B1
6381493 Stadler et al. Apr 2002 B1
6381494 Gilkerson et al. Apr 2002 B1
6383209 Crowley May 2002 B1
6385593 Linberg May 2002 B2
6386882 Linberg May 2002 B1
6397100 Stadler et al. May 2002 B2
6402689 Scarantino et al. Jun 2002 B1
6405073 Crowley et al. Jun 2002 B1
6405083 Rockwell et al. Jun 2002 B1
6409674 Brockway et al. Jun 2002 B1
6409675 Turcott Jun 2002 B1
6412490 Lee Jul 2002 B1
6418346 Nelson et al. Jul 2002 B1
6423056 Ishikawa et al. Jul 2002 B1
6424866 Mika et al. Jul 2002 B2
6428484 Battmer et al. Aug 2002 B1
6434429 Kraus et al. Aug 2002 B1
6438410 Hsu et al. Aug 2002 B2
6438417 Rockwell et al. Aug 2002 B1
6442433 Linberg Aug 2002 B1
6444970 Barbato Sep 2002 B1
6445953 Bulkes et al. Sep 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6459928 Mika et al. Oct 2002 B2
6459937 Morgan et al. Oct 2002 B1
6466820 Juran et al. Oct 2002 B1
6468263 Fischell et al. Oct 2002 B1
6470215 Kraus et al. Oct 2002 B1
6471645 Warkentin et al. Oct 2002 B1
6472991 Schulman et al. Oct 2002 B1
6477424 Thompson et al. Nov 2002 B1
6480733 Turcott Nov 2002 B1
6482154 Haubrich et al. Nov 2002 B1
6484055 Marcovecchio Nov 2002 B1
6484057 Ideker et al. Nov 2002 B2
6490487 Kraus et al. Dec 2002 B1
6496715 Lee et al. Dec 2002 B1
6500168 Jellie Dec 2002 B1
6501983 Natarajan et al. Dec 2002 B1
6512949 Combs et al. Jan 2003 B1
6512959 Gomperz et al. Jan 2003 B1
6522926 Kieval et al. Feb 2003 B1
6522928 Whitehurst et al. Feb 2003 B2
6539257 KenKnight Mar 2003 B1
6556860 Groenewegen Apr 2003 B1
6558321 Burd et al. May 2003 B1
6564807 Schulman et al. May 2003 B1
6567680 Swetlik et al. May 2003 B2
6571120 Hutten May 2003 B2
6574509 Kraus et al. Jun 2003 B1
6574511 Lee Jun 2003 B2
6580946 Struble Jun 2003 B2
6580948 Haupert et al. Jun 2003 B2
6584351 Ekwall Jun 2003 B1
6584352 Combs et al. Jun 2003 B2
6589187 Dirnberger et al. Jul 2003 B1
6592518 Denker et al. Jul 2003 B2
6594523 Levine Jul 2003 B1
6597948 Rockwell et al. Jul 2003 B1
6597952 Mika et al. Jul 2003 B1
6609023 Fischell et al. Aug 2003 B1
6611710 Gomperz et al. Aug 2003 B2
6615075 Mlynash et al. Sep 2003 B2
6622043 Kraus et al. Sep 2003 B1
6647292 Bardy et al. Nov 2003 B1
6648823 Thompson Nov 2003 B2
6649078 Yu Nov 2003 B2
6654638 Sweeney Nov 2003 B1
6658285 Potse et al. Dec 2003 B2
6658297 Loeb Dec 2003 B2
6658301 Loeb et al. Dec 2003 B2
6659959 Brockway et al. Dec 2003 B2
6669631 Norris et al. Dec 2003 B2
6681135 Davis et al. Jan 2004 B1
6684100 Sweeney et al. Jan 2004 B1
6687540 Marcovecchio Feb 2004 B2
6687546 Lebel et al. Feb 2004 B2
6689117 Sweeney et al. Feb 2004 B2
6690959 Thompson Feb 2004 B2
6694191 Starkweather et al. Feb 2004 B2
6695885 Schulman et al. Feb 2004 B2
6697672 Andersson Feb 2004 B2
6699200 Cao et al. Mar 2004 B2
6702857 Brauker et al. Mar 2004 B2
6704602 Berg et al. Mar 2004 B2
6711440 Deal et al. Mar 2004 B2
6721597 Bardy et al. Apr 2004 B1
6728572 Hsu et al. Apr 2004 B2
6728574 Ujhelyi et al. Apr 2004 B2
6731976 Penn et al. May 2004 B2
6731979 MacDonald May 2004 B2
6733485 Whitehurst et al. May 2004 B1
6735474 Loeb et al. May 2004 B1
6738670 Almendinger et al. May 2004 B1
6741877 Shults et al. May 2004 B1
6741886 Yonce May 2004 B2
6746404 Schwartz Jun 2004 B2
6754538 Linberg Jun 2004 B2
6760620 Sippens Groenewegen Jul 2004 B2
6764446 Wolinsky et al. Jul 2004 B2
6768923 Ding et al. Jul 2004 B2
6783499 Schwartz Aug 2004 B2
6785576 Verness Aug 2004 B2
6786860 Maltan et al. Sep 2004 B2
6792314 Byers et al. Sep 2004 B2
6799069 Weiner et al. Sep 2004 B2
6804559 Kraus et al. Oct 2004 B1
6804561 Stover Oct 2004 B2
6809507 Morgan et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6821154 Canfield et al. Nov 2004 B1
6823217 Rutten et al. Nov 2004 B2
6824512 Warkentin et al. Nov 2004 B2
6829508 Schulman et al. Dec 2004 B2
6839596 Nelson et al. Jan 2005 B2
6848052 Hamid et al. Jan 2005 B2
6850801 Kieval et al. Feb 2005 B2
6862465 Shults et al. Mar 2005 B2
6862480 Cohen et al. Mar 2005 B2
6865420 Kroll Mar 2005 B1
6869404 Schulhauser et al. Mar 2005 B2
6871099 Whitehurst et al. Mar 2005 B1
6878112 Linberg et al. Apr 2005 B2
6879695 Maltan et al. Apr 2005 B2
6879855 Schulman et al. Apr 2005 B2
6882875 Crowley Apr 2005 B1
6889081 Hsu May 2005 B2
6893395 Kraus et al. May 2005 B1
6895279 Loeb et al. May 2005 B2
6895281 Amundson et al. May 2005 B1
6896651 Gross et al. May 2005 B2
6897788 Khair et al. May 2005 B2
6901294 Whitehurst et al. May 2005 B1
6901296 Whitehurst et al. May 2005 B1
6907285 Denker et al. Jun 2005 B2
6907293 Grill et al. Jun 2005 B2
6912420 Scheiner et al. Jun 2005 B2
6917833 Denker et al. Jul 2005 B2
6925328 Foster et al. Aug 2005 B2
6931327 Goode, Jr. et al. Aug 2005 B2
6999821 Jenney et al. Feb 2006 B2
7001372 Richter Feb 2006 B2
7023359 Goetz et al. Apr 2006 B2
7146222 Boling Dec 2006 B2
7146225 Guenst et al. Dec 2006 B2
7164950 Kroll et al. Jan 2007 B2
7181505 Haller et al. Feb 2007 B2
7187971 Sommer et al. Mar 2007 B2
7200437 Nabutovsky et al. Apr 2007 B1
7289853 Campbell et al. Oct 2007 B1
7363090 Halperin et al. Apr 2008 B2
7558631 Cowan et al. Jul 2009 B2
7565195 Kroll et al. Jul 2009 B1
7630767 Poore et al. Dec 2009 B1
7634313 Kroll et al. Dec 2009 B1
20020099430 Verness Jul 2002 A1
20020116028 Greatbatch et al. Aug 2002 A1
20020147488 Doan et al. Oct 2002 A1
20030040666 Rutten et al. Feb 2003 A1
20030163184 Scheiner Aug 2003 A1
20040011366 Schulman et al. Jan 2004 A1
20040143262 Visram et al. Jul 2004 A1
20040147973 Hauser Jul 2004 A1
20040167587 Thompson Aug 2004 A1
20040172116 Seifert et al. Sep 2004 A1
20040193223 Kramer et al. Sep 2004 A1
20040249417 Ransbury et al. Dec 2004 A1
20040260349 Stroebel Dec 2004 A1
20050038474 Wool Feb 2005 A1
20050096702 Denker et al. May 2005 A1
20050131478 Kim et al. Jun 2005 A1
20050149138 Min et al. Jul 2005 A1
20050165465 Pianca et al. Jul 2005 A1
20050267555 Marnfeldt et al. Dec 2005 A1
20050288722 Eigler et al. Dec 2005 A1
20060085039 Hastings et al. Apr 2006 A1
20060085041 Hastings et al. Apr 2006 A1
20060085042 Hastings et al. Apr 2006 A1
20060121475 Davids et al. Jun 2006 A1
20060135999 Bodner et al. Jun 2006 A1
20060136004 Cowan et al. Jun 2006 A1
20060161222 Haubrich et al. Jul 2006 A1
20060241705 Neumann et al. Oct 2006 A1
20060247750 Seifert et al. Nov 2006 A1
20070088394 Jacobson Apr 2007 A1
20070088396 Jacobson Apr 2007 A1
20070088397 Jacobson Apr 2007 A1
20070088398 Jacobson Apr 2007 A1
20070088405 Jacobson Apr 2007 A1
20070088418 Jacobson Apr 2007 A1
20070276004 Hirsch et al. Nov 2007 A1
20070293904 Gelbart et al. Dec 2007 A1
20080004535 Smits Jan 2008 A1
20080119911 Rosero May 2008 A1
20080269591 Halperin et al. Oct 2008 A1
20090082828 Ostroff Mar 2009 A1
20090171408 Solem Jul 2009 A1
Foreign Referenced Citations (5)
Number Date Country
1741465 Jan 2007 EP
WO 9837926 Sep 1998 WO
WO 2006065394 Jun 2006 WO
WO 2007047681 Apr 2007 WO
WO 2007059386 May 2007 WO
Related Publications (1)
Number Date Country
20070088400 A1 Apr 2007 US
Provisional Applications (7)
Number Date Country
60726706 Oct 2005 US
60729671 Oct 2005 US
60737296 Nov 2005 US
60739901 Nov 2005 US
60749017 Dec 2005 US
60761531 Jan 2006 US
60761740 Jan 2006 US